| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| O381 Bleeding pattern and safety of repeat use of the LNG-IUS: resultsof a multicenter prospective study |
Heikinheimo, O.;Gemzell-Danielsson, K.;Inki, P.;Kunz, M.;Boubli, L.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| P723 Ethinylestradiol 20 mcg/drospirenone 3 mg combined oralcontraceptive administered in a 24/4 regimen in the treatment ofpremenstrual dysphoric disorder-related symptoms and functional impairment:a randomized, multicenter, double-blind, parallel study |
Marr, J.;Heinemann, K.;Kunz, M.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| P727 A pooled analysis of two randomized, placebo-controlled studiesinvestigating an oral contraceptive containing ethinylestradiol 20mcg/drospirenone 3 mg in a 24/4 regimen in the treatment of acne: lesioncounts and investigator & subject assessments |
Koltun, W.;Maloney, J.;Marr, J.;Kunz, M.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| P728 Ethinylestradiol 20 mcg/drospirenone 3 mg oral contraceptiveadministered in 24/4 regimen in the treatment of moderate acne vulgaris: apooled analysis of two randomized, double-blind, placebo-controlled studies |
Koltun, W.;Maloney, J.;Marr, J.;Kunz, M.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| P734 A historical cycle control comparison of twodrospirenone-containing combined oral contraceptives: ethinylestradiol 30mcg/drospirenone 3 mg administered in a 21/7 regimen versusethinylestradiol 20 mcg/drospirenone 3 mg administered in a 24/4 regimen |
Bachmann, G.;Kunz, M.;Marr, J.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| P735 Contraceptive efficacy of a combined oral contraceptive containingethinylestradiol 20 mcg/drospirenone 3 mg administered in 24/4 regimen: apooled analysis of four, open-label studies |
Anttila, L.;Kunz, M.;Marr, J.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| A 60-month non-comparative study on bleeding profiles with thelevonorgestrel intrauterine system from the late transition period toestrogen supplemented menopause |
Depypere, H.T.;Hillard, T.;Erkkola, R.;Lukkari-Lax, E.;Kunz, M.;Rautiainen, P.;Schram, J.H.N.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2010-12-01 |
查看 |
| Ethinyl estradiol 20@mg/drospirenone 3mg 24/4 oral contraceptive forthe treatment of functional impairment in women with premenstrual dysphoricdisorder |
Marr, J.;Heinemann, K.;Kunz, M.;Rapkin, A.; |
International Journal of Gynecology & Obstetrics |
2011-05-01 |
查看 |
| Contraceptive efficacy of a combined oral contraceptive containingethinyloestradiol 20@mg/drospirenone 3mg administered in a 24/4 regimen: apooled analysis of four open-label studies |
Anttila, L.;Bachmann, G.;Hernadi, L.;Kunz, M.;Marr, J.;Klipping, C.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2011-04-01 |
查看 |
| Treatment of moderate acne vulgaris using a combined oral contraceptivecontaining ethinylestradiol 20@mg plus drospirenone 3mg administered in a24/4 regimen: a pooled analysis |
Koltun, W.;Maloney, J.M.;Marr, J.;Kunz, M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2011-04-01 |
查看 |
| A historical cycle control comparison of two drospirenone-containingcombined oral contraceptives: ethinylestradiol 30@mg/drospirenone 3mgadministered in a 21/7 regimen versus ethinylestradiol 20@mg/drospirenone3mg administered in a 24/4 regimen |
Marr, J.;Gerlinger, C.;Kunz, M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2012-05-01 |
查看 |
|
|
